Results 141 to 150 of about 60,035 (201)

[Pharmacokinetic interaction between linezolid and rifampicin: A case report]. [PDF]

Rev Esp Quimioter
Fernández-Vázquez A, Ayala-Álvarez-Canal J, García González D, Sáez-Villafañe M, Dios-Díez P, Ortiz-de-Urbina-González JJ.   +5 more
europepmc   +1 more source

Antibiofilm and antibacterial activity of maslinic acid against Vancomycin-Resistant Enterococci (VRE). [PDF]

PLoS One
Abdelmegeed SM, Mohamed MF, Seleem MN.
europepmc   +1 more source

High efficacy of BPaL among patients infected with <i>Mycobacterium tuberculosis</i> lineage 1 in the Philippines. [PDF]

IJTLD Open
Flores I, Tujan MAA, Basilio R, Dizon TJR, Lim DR, Reyes LT, Reyes RVAG, Rojas S, Valencia AK, Capin JB, Mirtskhulava V, Palparan AG, Cabalitan C, Carpin PJ, Malbacias C, Lee JS, Gebhard A, Quelapio M, Timm J.   +18 more
europepmc   +1 more source

Health Technology Assessment of Oxazolidinones for MRSA-Associated Complicated Skin and Soft Tissue Infections. [PDF]

Drug Des Devel Ther
Zhao Y, Huang B, Yang Z, Kuang H, Chen J.   +4 more
europepmc   +1 more source

Molecular Characterization of Linezolid-Non-Susceptible <i>Enterococcus faecium</i>: Identification of <i>optrA and vanM</i> Co-Harboring Strain in Clinical Isolate from China. [PDF]

Infect Drug Resist
Shen H, Chen X, Liu J, Wei M, Yang C, Gu L, Zhu W, Li R.   +7 more
europepmc   +1 more source

Effect of traumatic brain injury on the trough concentration of linezolid in patients with hospital-acquired pneumonia. [PDF]

Sci Rep
Zhang Y, Tang L, Ma M, Zhuang Z, Xu J, Shi L, Zhang Q, Yu Y, Yu Z, Xu G.   +9 more
europepmc   +1 more source

Adverse Drug Reaction to Linezolid in Drug-Resistant Tuberculosis: A Systematic Review. [PDF]

Med Sci (Basel)
Oktaviani E, Anggadiredja K, Amalia L.
europepmc   +1 more source

Development and validation of a nomogram for predicting thrombocytopenia in sepsis patients treated with linezolid. [PDF]

BMC Pharmacol Toxicol
Yang S, Hu L, Liu G, Yuan X, Chen X.
europepmc   +1 more source

<i>In vitro</i> activity of MRS-2541, a novel MetRS inhibitor, against a selection of resistant gram-positive organisms associated with serious hospital infections. [PDF]

Microbiol Spectr
Domagala J, Jahanbakhsh S, Mendez AK, Pillar CM, Marra A, Hufnagel DA, Molasky NMR, Zhang Z, Fan E, Reyna D, Lipka E, Buckner FS.   +11 more
europepmc   +1 more source

Environmental occurrence of optrA-mediated linezolid resistance in Enterococcus isolates and genomic insights into Enterococcus faecium ST54 co-harboring optrA, poxtA, and cfr(D) genes. [PDF]

World J Microbiol Biotechnol
Dos Santos LDR, Furlan JPR, da Silva Rosa R, Ramos MS, Gervasoni LF, Savazzi EA, Nogueira T, Stehling EG.   +7 more
europepmc   +1 more source